Literature DB >> 24984783

Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1.

Ravindra Boddu1, Chaozhe Yang, Amber K O'Connor, Robert Curtis Hendrickson, Braden Boone, Xiangqin Cui, Miguel Garcia-Gonzalez, Peter Igarashi, Luiz F Onuchic, Gregory G Germino, Lisa M Guay-Woodford.   

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) results from mutations in the human PKHD1 gene. Both this gene, and its mouse ortholog, Pkhd1, are primarily expressed in renal and biliary ductal structures. The mouse protein product, fibrocystin/polyductin complex (FPC), is a 445-kDa protein encoded by a 67-exon transcript that spans >500 kb of genomic DNA. In the current study, we observed multiple alternatively spliced Pkhd1 transcripts that varied in size and exon composition in embryonic mouse kidney, liver, and placenta samples, as well as among adult mouse pancreas, brain, heart, lung, testes, liver, and kidney. Using reverse transcription PCR and RNASeq, we identified 22 novel Pkhd1 kidney transcripts with unique exon junctions. Various mechanisms of alternative splicing were observed, including exon skipping, use of alternate acceptor/donor splice sites, and inclusion of novel exons. Bioinformatic analyses identified, and exon-trapping minigene experiments validated, consensus binding sites for serine/arginine-rich proteins that modulate alternative splicing. Using site-directed mutagenesis, we examined the functional importance of selected splice enhancers. In addition, we demonstrated that many of the novel transcripts were polysome bound, thus likely translated. Finally, we determined that the human PKHD1 R760H missense variant alters a splice enhancer motif that disrupts exon splicing in vitro and is predicted to truncate the protein. Taken together, these data provide evidence of the complex transcriptional regulation of Pkhd1/PKHD1 and identified motifs that regulate its splicing. Our studies indicate that Pkhd1/PKHD1 transcription is modulated, in part by intragenic factors, suggesting that aberrant PKHD1 splicing represents an unappreciated pathogenic mechanism in ARPKD. Key messages: Multiple mRNA transcripts are generated for Pkhd1 in renal tissues Pkhd1 transcription is modulated by standard splice elements and effectors Mutations in splice motifs may alter splicing to generate nonfunctional peptides.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24984783      PMCID: PMC4197071          DOI: 10.1007/s00109-014-1185-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  33 in total

1.  Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector.

Authors:  T C Burn; T D Connors; K W Klinger; G M Landes
Journal:  Gene       Date:  1995-08-19       Impact factor: 3.688

2.  PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats.

Authors:  Luiz F Onuchic; Laszlo Furu; Yasuyuki Nagasawa; Xiaoying Hou; Thomas Eggermann; Zhiyong Ren; Carsten Bergmann; Jan Senderek; Ernie Esquivel; Raoul Zeltner; Sabine Rudnik-Schöneborn; Michael Mrug; William Sweeney; Ellis D Avner; Klaus Zerres; Lisa M Guay-Woodford; Stefan Somlo; Gregory G Germino
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

Review 3.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

4.  The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area.

Authors:  Shixuan Wang; Ying Luo; Patricia D Wilson; George B Witman; Jing Zhou
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

5.  Autosomal recessive polycystic kidney disease: the clinical experience in North America.

Authors:  Lisa M Guay-Woodford; Renee A Desmond
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

6.  Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm.

Authors:  Luís F C Menezes; Yiqiang Cai; Yasuyuki Nagasawa; Ana M G Silva; Mary L Watkins; Aline M Da Silva; Stefan Somlo; Lisa M Guay-Woodford; Gregory G Germino; Luiz F Onuchic
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

7.  Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia.

Authors:  Christopher J Ward; David Yuan; Tatyana V Masyuk; Xiaofang Wang; Rachaneekorn Punyashthiti; Shelly Whelan; Robert Bacallao; Roser Torra; Nicholas F LaRusso; Vicente E Torres; Peter C Harris
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

8.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

9.  Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene.

Authors:  Yasuyuki Nagasawa; Sonja Matthiesen; Luiz F Onuchic; Xiaoying Hou; Carsten Bergmann; Ernie Esquivel; Jan Senderek; Zhiyong Ren; Raoul Zeltner; Laszlo Furu; Ellis Avner; Markus Moser; Stefan Somlo; Lisa Guay-Woodford; Reinhard Büttner; Klaus Zerres; Gregory G Germino
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

10.  Variation in alternative splicing across human tissues.

Authors:  Gene Yeo; Dirk Holste; Gabriel Kreiman; Christopher B Burge
Journal:  Genome Biol       Date:  2004-09-13       Impact factor: 13.583

View more
  14 in total

1.  Preparation of Disease-Related Protein Assemblies for Single Particle Electron Microscopy.

Authors:  A Cameron Varano; Naoe Harafuji; William Dearnaley; Lisa Guay-Woodford; Deborah F Kelly
Journal:  Methods Mol Biol       Date:  2017

2.  Aberrant transcriptional regulation could explain phenotypic variability in autosomal recessive polycystic kidney disease.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2014-10       Impact factor: 4.599

Review 3.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

4.  A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Authors:  Patricia Outeda; Luis Menezes; Erum A Hartung; Stacey Bridges; Fang Zhou; Xianjun Zhu; Hangxue Xu; Qiong Huang; Qin Yao; Feng Qian; Gregory G Germino; Terry Watnick
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

5.  The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.

Authors:  Corinne Antignac; James P Calvet; Gregory G Germino; Jared J Grantham; Lisa M Guay-Woodford; Peter C Harris; Friedhelm Hildebrandt; Dorien J M Peters; Stefan Somlo; Vicente E Torres; Gerd Walz; Jing Zhou; Alan S L Yu
Journal:  J Am Soc Nephrol       Date:  2015-05-07       Impact factor: 10.121

6.  Challenges in establishing genotype-phenotype correlations in ARPKD: case report on a toddler with two severe PKHD1 mutations.

Authors:  Kathrin Ebner; Claudia Dafinger; Nadina Ortiz-Bruechle; Friederike Koerber; Bernhard Schermer; Thomas Benzing; Jörg Dötsch; Klaus Zerres; Lutz Thorsten Weber; Bodo B Beck; Max Christoph Liebau
Journal:  Pediatr Nephrol       Date:  2017-03-31       Impact factor: 3.714

7.  Rationale, design and objectives of ARegPKD, a European ARPKD registry study.

Authors:  Kathrin Ebner; Markus Feldkoetter; Gema Ariceta; Carsten Bergmann; Reinhard Buettner; Anke Doyon; Ali Duzova; Heike Goebel; Dieter Haffner; Barbara Hero; Bernd Hoppe; Thomas Illig; Augustina Jankauskiene; Norman Klopp; Jens König; Mieczyslaw Litwin; Djalila Mekahli; Bruno Ranchin; Anja Sander; Sara Testa; Lutz Thorsten Weber; Dorota Wicher; Ayse Yuzbasioglu; Klaus Zerres; Jörg Dötsch; Franz Schaefer; Max Christoph Liebau
Journal:  BMC Nephrol       Date:  2015-02-18       Impact factor: 2.388

8.  NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology.

Authors:  Jun-Ya Kaimori; Cheng-Chao Lin; Patricia Outeda; Miguel A Garcia-Gonzalez; Luis F Menezes; Erum A Hartung; Ao Li; Guanqing Wu; Hideaki Fujita; Yasunori Sato; Yasuni Nakanuma; Satoko Yamamoto; Naotsugu Ichimaru; Shiro Takahara; Yoshitaka Isaka; Terry Watnick; Luiz F Onuchic; Lisa M Guay-Woodford; Gregory G Germino
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

Review 9.  Emerging Therapies for Childhood Polycystic Kidney Disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Front Pediatr       Date:  2017-04-19       Impact factor: 3.418

10.  Intragenic duplication in the PKHD1 gene in autosomal recessive polycystic kidney disease.

Authors:  Jun Miyazaki; Mayuko Ito; Haruki Nishizawa; Takema Kato; Yukito Minami; Hidehito Inagaki; Tamae Ohye; Masafumi Miyata; Hiroko Boda; Yuka Kiriyama; Makoto Kuroda; Takao Sekiya; Hiroki Kurahashi; Takuma Fujii
Journal:  BMC Med Genet       Date:  2015-10-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.